Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2886830 | Annals of Vascular Surgery | 2013 | 9 Pages |
Abstract
Application of a RE framework to the assessment of clinical outcomes after peripheral interventions is feasible, and potentially more informative than traditional techniques. Conceptualization of interventions as “products” permits application of product life-cycle models that allow for empiric definition of “early failure” may facilitate comparative effectiveness analysis and enable the development of individualized surveillance programs after endovascular interventions.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Andrew J. Meltzer, Ashley Graham, Peter H. Connolly, John K. Karwowski, Harry L. Bush, Peter I. Frazier, Darren B. Schneider,